FFCP PHASE1:Mm9::chrX:137040387..137040413,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chrX:137040387..137040413,-|id=chrX:137040387..137040413,-|ontology_enrichment_celltype=CL:0000988!4.03e-09!32;CL:0002032!4.03e-09!32;CL:0000037!4.03e-09!32;CL:0000566!4.03e-09!32;CL:0000837!4.03e-09!32;CL:0002031!8.87e-09!25;CL:0002320!1.60e-07!46;CL:0000134!1.60e-07!46;CL:0000738!2.43e-07!17;CL:0002087!2.43e-07!17;CL:0000219!8.56e-07!54|ontology_enrichment_celltype_v019_2=CL:0000624,1.73e-09,8;CL:0000815,2.52e-09,1;CL:0000792,2.52e-09,1;CL:0000355,8.73e-09,9;CL:0000791,1.69e-08,9;CL:0000789,1.69e-08,9;CL:0002420,1.69e-08,9;CL:0002419,1.69e-08,9;CL:0000790,1.69e-08,9;CL:0000738,1.08e-07,17;CL:0002087,1.08e-07,17;CL:0000084,4.73e-07,11;CL:0000827,4.73e-07,11|ontology_enrichment_disease=DOID:0060100!4.01e-08!3;DOID:4045!4.01e-08!3|ontology_enrichment_disease_v019_2=DOID:0060100,4.47e-25,3;DOID:4045,4.47e-25,3;DOID:0050686,6.95e-13,6|ontology_enrichment_uberon=UBERON:0002384!1.60e-07!46|ontology_enrichment_uberon_v019_2=UBERON:0001134,8.73e-09,9;UBERON:0002036,8.73e-09,9;UBERON:0002385,8.73e-09,9;UBERON:0000486,8.73e-09,9;UBERON:0007503,8.73e-09,9;UBERON:0001015,8.73e-09,9;UBERON:0002329,8.73e-09,9;UBERON:0003082,8.73e-09,9;UBERON:0003059,8.73e-09,9;UBERON:0007282,8.73e-09,9;UBERON:0004290,8.73e-09,9;UBERON:0009618,8.73e-09,9;UBERON:0000383,5.83e-08,10;UBERON:0007524,2.77e-07,11;UBERON:0003077,2.77e-07,11;UBERON:0007285,2.77e-07,11|phase1_expression=0,0,0,0,0,0,0,5.29405626110463,0,0,0,0,2.73921167889929,1.66098764596095,0,0,0,0.473193248037357,0.548457734422955,0.84877930359606,0,0.198581902401771,0,0,0,0,0,0,0,0,0,0,0,0,0.288851619751275,0,0.204169356262369,10.4632907684227,5.4693474116666,6.80580867165938,36.4703522579229,17.0761371239611,3.39857247121808,0,0,0,0,0,0,0,0,0,0.503347818173209,0,0.672187598284928,0,0,0,0,0,0,0.338844532069132,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.151143120213571,0.289864488701678,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11418387971906,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.19980546198682,0.381210681219194,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0937017245597288,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0810688095458557,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.184753190166605,0,0,0,0,0,0,0.195133647857799,0,0,0,0,0,0.144649058581512,1.50791283939272,0.54390568381871,0,0,0,0,0,0.252470927204373,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.161464426695906,0,0,0,0,0,0.170870880797853,0,0,0,0,0,0.169978429993855,0.419854356970974,0.414599921413271,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0762068066549998,0,0,0.0962118416403295,0.584384510907845,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.320919209591815,0,0,0,0,0.128050304809739,0,0,0,0,0,0,0,0,0,0,0,0,0.182927972872773,0,0,0,0.118635018124174,0,0,0,0,0,0,0,0.191288332068843,0,0|short_description=p@chrX:137040387..137040413,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chrX:137040387..137040413,- | |||
|description=CAGE_peak_at_chrX:137040387..137040413,- | |||
|id=chrX:137040387..137040413,- | |||
|ontology_enrichment_celltype=CL:0000988!4.03e-09!32;CL:0002032!4.03e-09!32;CL:0000037!4.03e-09!32;CL:0000566!4.03e-09!32;CL:0000837!4.03e-09!32;CL:0002031!8.87e-09!25;CL:0002320!1.60e-07!46;CL:0000134!1.60e-07!46;CL:0000738!2.43e-07!17;CL:0002087!2.43e-07!17;CL:0000219!8.56e-07!54 | |||
|ontology_enrichment_celltype_v019_2=CL:0000624,1.73e-09,8;CL:0000815,2.52e-09,1;CL:0000792,2.52e-09,1;CL:0000355,8.73e-09,9;CL:0000791,1.69e-08,9;CL:0000789,1.69e-08,9;CL:0002420,1.69e-08,9;CL:0002419,1.69e-08,9;CL:0000790,1.69e-08,9;CL:0000738,1.08e-07,17;CL:0002087,1.08e-07,17;CL:0000084,4.73e-07,11;CL:0000827,4.73e-07,11 | |||
|ontology_enrichment_disease=DOID:0060100!4.01e-08!3;DOID:4045!4.01e-08!3 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,4.47e-25,3;DOID:4045,4.47e-25,3;DOID:0050686,6.95e-13,6 | |||
|ontology_enrichment_uberon=UBERON:0002384!1.60e-07!46 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,8.73e-09,9;UBERON:0002036,8.73e-09,9;UBERON:0002385,8.73e-09,9;UBERON:0000486,8.73e-09,9;UBERON:0007503,8.73e-09,9;UBERON:0001015,8.73e-09,9;UBERON:0002329,8.73e-09,9;UBERON:0003082,8.73e-09,9;UBERON:0003059,8.73e-09,9;UBERON:0007282,8.73e-09,9;UBERON:0004290,8.73e-09,9;UBERON:0009618,8.73e-09,9;UBERON:0000383,5.83e-08,10;UBERON:0007524,2.77e-07,11;UBERON:0003077,2.77e-07,11;UBERON:0007285,2.77e-07,11 | |||
|phase1_expression=0,0,0,0,0,0,0,5.29405626110463,0,0,0,0,2.73921167889929,1.66098764596095,0,0,0,0.473193248037357,0.548457734422955,0.84877930359606,0,0.198581902401771,0,0,0,0,0,0,0,0,0,0,0,0,0.288851619751275,0,0.204169356262369,10.4632907684227,5.4693474116666,6.80580867165938,36.4703522579229,17.0761371239611,3.39857247121808,0,0,0,0,0,0,0,0,0,0.503347818173209,0,0.672187598284928,0,0,0,0,0,0,0.338844532069132,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.151143120213571,0.289864488701678,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11418387971906,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.19980546198682,0.381210681219194,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0937017245597288,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0810688095458557,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.184753190166605,0,0,0,0,0,0,0.195133647857799,0,0,0,0,0,0.144649058581512,1.50791283939272,0.54390568381871,0,0,0,0,0,0.252470927204373,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.161464426695906,0,0,0,0,0,0.170870880797853,0,0,0,0,0,0.169978429993855,0.419854356970974,0.414599921413271,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0762068066549998,0,0,0.0962118416403295,0.584384510907845,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.320919209591815,0,0,0,0,0.128050304809739,0,0,0,0,0,0,0,0,0,0,0,0,0.182927972872773,0,0,0,0.118635018124174,0,0,0,0,0,0,0,0.191288332068843,0,0 | |||
|short_description=p@chrX:137040387..137040413,- | |||
}} |
Latest revision as of 01:11, 6 August 2015
Short description: | p@chrX:137040387..137040413, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chrX:137040387..137040413, - |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
CD4-positive, alpha-beta T cell | 1.73e-09 | 8 |
regulatory T cell | 2.52e-09 | 1 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell | 2.52e-09 | 1 |
multi-potent skeletal muscle stem cell | 8.73e-09 | 9 |
mature alpha-beta T cell | 1.69e-08 | 9 |
alpha-beta T cell | 1.69e-08 | 9 |
immature T cell | 1.69e-08 | 9 |
mature T cell | 1.69e-08 | 9 |
immature alpha-beta T cell | 1.69e-08 | 9 |
leukocyte | 1.08e-07 | 17 |
nongranular leukocyte | 1.08e-07 | 17 |
T cell | 4.73e-07 | 11 |
pro-T cell | 4.73e-07 | 11 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 8.73e-09 | 9 |
striated muscle tissue | 8.73e-09 | 9 |
muscle tissue | 8.73e-09 | 9 |
multilaminar epithelium | 8.73e-09 | 9 |
epithelial vesicle | 8.73e-09 | 9 |
musculature | 8.73e-09 | 9 |
somite | 8.73e-09 | 9 |
myotome | 8.73e-09 | 9 |
presomitic mesoderm | 8.73e-09 | 9 |
presumptive segmental plate | 8.73e-09 | 9 |
dermomyotome | 8.73e-09 | 9 |
trunk paraxial mesoderm | 8.73e-09 | 9 |
musculature of body | 5.83e-08 | 10 |
dense mesenchyme tissue | 2.77e-07 | 11 |
paraxial mesoderm | 2.77e-07 | 11 |
presumptive paraxial mesoderm | 2.77e-07 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 4.47e-25 | 3 |
muscle cancer | 4.47e-25 | 3 |
organ system cancer | 6.95e-13 | 6 |